SWORD 1&2: maintenance or improvement in renal function in PLWH through 148 weeks after switch to the dolutegravir plus rilpivirine 2-drug regimenJ. M. Llibre,E. Voronin,R. Rubio,P-M Girard, F. Bredeek,J. van Wyk,L. Kahl,B. Jones,L. Curtis,B. Wynne,M. Nascimento,J. Koteff,M. Gartland,K. Angelis,K. Vandermeulen,K. Y. SmithHIV MEDICINE（2019）引用 0|浏览28AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
